Kadir Uğur MERT, Göknur YORULMAZ, Selda MURAT, Muhammet DURAL, Elif Sevil ALAGÜNEY, Ahmet Serdar YILMAZ, Nur KEBAPÇI, Ezgi CAMLI, Belgin EFE, Aysen AKALIN, Ahmet Toygar KALKAN

Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients

Background/aim: It is known that the presence of fragmented QRS (fQRS) on electrocardiography (ECG) is associated with cardiovascular events. The aim of this study was the evaluation of fQRS formation and its relationship with the left ventricular hypertrophy (LVH) parameters in acromegaly patients. Materials and methods: In total, 47 previously diagnosed with non-hypertensive acromegaly patients and 48 control subjects were included in the study. ECG and transthoracic echocardiography (TTE) were performed for each participant. Acromegaly patients were divided into two groups according to the fQRS formation on the ECG. Left ventricular wall thicknesses, and left atrial diameter (LAD), left ventricular mass (LVM), left ventricular mass index (LVMi), and relative wall thickness (RWT) were obtained. Results: In control group 5 (10.4%) and in acromegaly group 17 (36.2%) patients had fQRS on ECG (p = 0.003). LAD [36.0 (34.0–38.0) vs. 38.0 (35.0–41.0) mm, p < 0.001], LVM [155.27 ± 27.00 vs. 173.0 (153.0–235.0) g, p < 0.001], LVMi [83.12 ± 13.19 vs. 92.0 (83.0–118.0) g/m², p < 0.001] and RWT [0.39 ± 0.03 vs. 0.43 (0.41–0.45), p = 0.001] were significantly higher in patients with acromegaly. Disease duration was significantly higher (11.59 ± 1.3 vs. 8.2 ± 1.8 years, p < 0.001) in the fQRS (+) group. LAD [41.0 (39.0–42.5) vs. 37.0 (34.7– 38.0) mm, p < 0.001], LVM [219.0 (160.5–254.5) vs. 164.0 (153.0–188.0) g, p = 0.017], LVMi [117.0 (92.5–128.5) vs. 86.0 (82.0–100.2) g/m², p = 0.013] and RWT [0.44 (0.42–0.49) vs. 0.43 (0.40–0.44), p = 0.037] were significantly higher in fQSR (+) acromegaly patients. In multivariate logistic regression analysis, disease duration (odds ratio: 10.05, 95% CI: 1.099–92.012, p = 0.041) and LAD (odds ratio: 2.19, 95% CI: 1.030–4.660, p = 0.042) were found to be the independent predictors of fQRS formation. Conclusion: The results of our study revealed that fQRS (+) acromegaly patients had increased LVH parameters compared to fQRS (-) patients.Key words: Acromegaly, fragmented QRS, left ventricular hypertrophy, left ventricular mass

PDF

___

1. Lopez-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM et al. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? The Journal of Clinical Endocrinology & Metabolism 1997; 82 (4): 1047-1053. doi:10.1210/jcem.82.4.3876
2. Dural M, Kabakci G, Cinar N, Erbas T, Canpolat U et al. Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly. Pituitary 2012; 17 (2): 163-170. doi: 10.1007/s11102-013-0482-4
3. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004; 25 (1): 102-152. doi:10.1210/er.2002-0022
4. Lopes MB. Growth hormone-secreting adenomas: pathology and cell biology. Neurosurgical Focus 2010; 29 (4): E2. doi:10.3171/2010.7.FOCUS10169
5. Colao A, Pivonello R, Grasso LF, Auriemma RS, Galdiero M et al. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. European Journal of Endocrinology 2011; 165 (5): 713-721. doi: 10.1530/ EJE-11-0408
6. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. New England Journal of Medicine 1999; 341 (17): 1276-1283. doi: 10.1056/NEJM199910213411706
7. Wahlander H, Isgaard J, Jennische E, Friberg P. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension 1992 19 (1): 25-32. doi: 10.1161/01.hyp.19.1.25
8. Fu ML, Tornell J, Schulze W, Hoebeke J, Isaksson OG et al. Myocardial hypertrophy in transgenic mice overexpressing the bovine growth hormone (bGH) gene. Journal of Internal Medicine 2999; 247 (5): 546-552. doi:10.1046/j.1365- 2796.2000.00651.x
9. Goldberg MD, Vadera N, Yandrapalli S, Frishman WH. Acromegalic cardiomyopathy: an overview of risk factors. Clinical Manifestations, and Therapeutic Options. Cardiology in Review 2018; 26 (6): 307-311. doi: 10.1097/ CRD.0000000000000215
10. Guo X, Gao L, Zhang S, Li Y, Wu Y et al. Cardiovascular system changes and related risk factors in acromegaly patients: a casecontrol study. International Journal of Endocrinology 2015: 573643. doi:10.1155/2015/573643
11. Akdeniz B, Gedik A, Turan O, Ozpelit E, Ikiz AO et al. Evaluation of left ventricular diastolic function according to new criteria and determinants in acromegaly. International Heart Journal 2012; 53 (5): 299-305. doi:10.1536/ihj.53.299
12. Jurcut R, Galoiu S, Florian A, Vladaia A, Ionita OR et al. Quantifying subtle changes in cardiovascular mechanics in acromegaly: a Doppler myocardial imaging study. Journal of Endocrinological Investigation 2014; 37 (11): 1081-1090. doi:10.1007/s40618-014-0147-9
13. Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K et al. Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database. Endocrine-Related Cancer 2017; 24 (10): 505-518. doi:10.1530/ERC-17-0253
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Journal of the American Society of Echocardiography 1989; 2 (5): 358-367. doi:10.1016/s0894-7317(89)80014-8
15. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. Journal of the American College of Cardiology 1992; 20 (5): 1251-1260. doi:10.1016/0735-1097(92)90385-z
16. Das MK, Khan B, Jacob S, Kumar A, Mahenthiran J. Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation 2006; 113 (21): 2495-2501. doi: 10.1161/CIRCULATIONAHA.105.595892
17. Das MK, Saha C, El Masry H, Peng J, Dandamudi G et al. Fragmented QRS on a 12-lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease. Heart Rhythm 2007; 4 (11): 1385-1392. doi: 10.1016/j. hrthm.2007.06.024
18. Korkmaz A, Yildiz A, Demir M, Ozyazgan B, Sahan E et al. The relationship between fragmented QRS and functional significance of coronary lesions. Journal of Electrocardiology 2017; 50 (3): 282-286. doi: 10.1016/j.jelectrocard.2017.01.005
19. Dural M, Sunman H, Algul E, Hocamguliyev H, Sahan HF et al. Relationship between serum bilirubin levels and presence of fragmented QRS in patients with acute coronary syndrome. Biomarkers in Medicine 2020; 14 (1): 65-73. doi:10.2217/bmm2018-0493
20. Luo G, Li Q, Duan J, Peng Y, Zhang Z. The predictive value of fragmented qrs for cardiovascular events in acute myocardial infarction: a systematic review and meta-analysis. Frontiers in Physiology 2020; 11: 1027. doi:10.3389/fphys.2020.01027
21. Dereli S, Ozer H, Ozer N, Bayramoglu A, Kaya A. Association between fragmented QRS and left ventricular dysfunction in acromegaly patients. Acta Cardiologica 2019; 1-7. doi:10.1080/ 00015385.2019.1610835
22. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update. Endocrine Practice 2011; 17 Suppl 4: 1-44. doi: 10.4158/ep.17.s4.1
23. Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF et al. A consensus statement on acromegaly therapeutic outcomes. Nature Reviews Endocrinology 2018; 14 (9): 552- 561. doi: 10.1038/s41574-018-0058-5
24. Picard MH, Adams D, Bierig SM, Dent JM, Douglas PS et al. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. Journal of the American Society of Echocardiography 2011; 24 (1): 1-10. doi: 10.1016/j.echo.2010.11.006
25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography 2005; 18 (12):1440-1463. doi: 10.1016/j. echo.2005.10.005
26. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. American Journal of Cardiology 1986; 57 (6): 450-458. doi:10.1016/0002- 9149(86)90771-x
27. Dohy Z, Vereckei A, Horvath V, Czimbalmos C, Szabo L et al. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy. Annals of Noninvasive Electrocardiology 2020; 25 (5): e12763. doi:10.1111/anec.12763
28. Fischer K, Marggraf M, Stark AW, Kaneko K, Aghayev A et al. Association of ECG parameters with late gadolinium enhancement and outcome in patients with clinical suspicion of acute or subacute myocarditis referred for CMR imaging. PLoS One 2020; 15 (1): e0227134. doi: 10.1371/journal. pone.0227134
29. Lorgis L, Cochet A, Chevallier O, Angue M, Gudjoncik A et al. Relationship between fragmented QRS and no-reflow, infarct size, and peri-infarct zone assessed using cardiac magnetic resonance in patients with myocardial infarction. Canadian Journal of Cardiology 2014; 30 (2): 204-210. doi: 10.1016/j. cjca.2013.11.026
30. Basaran Y, Tigen K, Karaahmet T, Isiklar I, Cevik C et al. Fragmented QRS complexes are associated with cardiac fibrosis and significant intraventricular systolic dyssynchrony in nonischemic dilated cardiomyopathy patients with a narrow QRS interval. Echocardiography 2011; 28 (1): 62-68. doi:10.1111/j.1540-8175.2010.01242.x
31. Lie JT. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. American Heart Journal 1980; 100 (1): 41-52. doi:10.1016/0002-8703(80)90277-x
32. Fazio S, Cittadini A, Sabatini D, Merola B, Colao AM et al. Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. European Heart Journal 1993; 14 (1): 26-33. doi:10.1093/eurheartj/14.1.26
33. Colao A, Grasso LFS, Di Somma C, Pivonello R. Acromegaly and heart failure. Heart Failure Clinics 2019; 15 (3): 399-408. doi:10.1016/j.hfc.2019.03.001
34. Sacca L, Napoli R, Cittadini A. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clinical Endocrinology 2003; 59 (6): 660-671. doi:10.1046/j.1365- 2265.2003.01780.x
35. Hoang K, Zhao Y, Gardin JM, Carnethon M, Mukamal K et al. LV mass as a predictor of CVD events in older adults with and without metabolic syndrome and diabetes. Journal of the American College of Cardiology Cardiovascular Imaging 2015; 8 (9): 1007-1015. doi:10.1016/j.jcmg.2015.04.019
36. Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA et al. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. Journal of the American College of Cardiology Cardiovascular Imaging 2012; 5 (8): 837-848. doi:10.1016/j.jcmg.2012.06.003
37. Walpot J, Massalha S, Hossain A, Small GR, Crean AM et al. Left ventricular mass is independently related to coronary artery atherosclerotic burden: feasibility of cardiac computed tomography to detect early geometric left ventricular changes. Journal of Thoracic Imaging 2020. doi: 10.1097/ RTI.0000000000000511
38. Vianna CB, Vieira ML, Mady C, Liberman B, Durazzo AE et al. Treatment of acromegaly improves myocardial abnormalities. American Heart Journal 2002; 143 (5): 873-876. doi:10.1067/ mhj.2002.122167
39. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? Journal of the American College of Cardiology 2006; 47 (5): 1018-1023. doi: 10.1016/j.jacc.2005.08.077
40. Zhu N, Chen H, Zhao X, Ye F, Jiang W et al. Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction. Medicine (Baltimore) 2019; 98 (48): e18146. doi:10.1097/MD.0000000000018146